Globoside (Gb4Cer), Ku80 autoantigen and α5β1 integrin have been identified as cell receptors/coreceptors for human parvovirus B19 (B19V), however, their role and mechanism of interaction with the virus is largely unknown. In UT7/Epo cells, expression of Gb4Cer and CD49e (Integrin alpha-5) was high but insignificant for Ku80. B19V co-localized with Gb4Cer and to a lesser extent with CD49e. However, only anti-Gb4Cer antibodies could disturb virus attachment. Only a small proportion of cell-bound viruses were able to internalize while the majority became detached from the receptor. When added to uninfected cells, the receptor-detached virus showed superior cell binding capacity and infectivity. Attachment of B19V to cells triggered conformational changes in the capsid leading to the accessibility of the Nterminus of VP1 (VP1u) to antibodies, which was maintained in the receptordetached virus. VP1u became similarly accessible to antibodies following incubation of B19V particles with increasing concentrations of purified Gb4Cer. The receptormediated exposure of VP1u is critical for virus internalization since capsids lacking VP1 could bind to cells but did not internalize. Moreover, an antibody against the Nterminus of VP1u disturbed virus internalization but only when present during and not after virus attachment, indicating the involvement of this region in binding events required for internalization. These results suggest that Gb4Cer is not only the primary receptor for B19V attachment but also the mediator of capsid rearrangements required for subsequent interactions leading to virus internalization.
Introduction
Human parvovirus B19 (B19V) belongs to the Erythrovirus genus of the Parvoviridae family. The virus has a worldwide distribution and typically causes a mild childhood febrile illness known as erythema infectiosum or fifth disease. In patients with underlying immunologic and hematologic disorders B19V has been associated with more severe manifestations such as arthropathies, aplastic anemia, hydrops fetalis and fetal death (4) .
B19V has a single-stranded DNA genome encapsidated in a T=1 nonenveloped icosahedral capsid. The capsid is assembled from two structural protein, VP1 (83 kDa) and VP2 (58 kDa). VP1 is identical to VP2 with the exception of 227-aa at the N-terminal part, the so-called VP1-unique region (VP1u) (9, 26) . Despite being the minor component of the capsid, the dominant immune response against B19V is elicited by the VP1u region, which harbors strong neutralizing epitopes (2, 31, 41) . A secreted phospholipase A2 (PLA2)-like activity has been located in the VP1 unique region of B19V (12) , which is required for the infection (13, 17, 40) . Despite all these properties, we have recently shown that VP1u is not accessible to antibodies.
However, brief exposure to mild temperatures or low pH can render this region accessible (30) . In this sense, B19V is similar to other parvoviruses in which VP1u is not accessible but can become exposed in vitro by mild heat or low pH treatments (10, 21) . In all parvoviruses tested so far, VP1u becomes exposed during the intracellular trafficking of the virus (18, 23, 28, 32, 33) . However, B19V-VP1u harbors strong neutralizing epitopes, meaning that its accessibility to antibody binding should The glycosphingolipid globoside (globotetraosylceramide; Gb4Cer) is the cellular receptor of B19V (5, 6) . Gb4Cer is largely expressed in the human erythroid progenitor cells in the bone marrow, which are the main target cells for the virus.
However, the pathogenicity and tropism of B19V cannot be explained if Gb4Cer is the only receptor. Previous studies have suggested that Gb4Cer is necessary for B19V to bind to cells, but is not sufficient for cell entry (35) . Subsequently, α5β1
integrin (36, 37) and Ku80 autoantigen (25) have been identified as coreceptors for B19V infection. While Ku80 might assist in virus attachment (25) ; α5β1 integrin is thought to be required for internalization (36, 37) . In line with a complex mechanism of internalization based on multiple receptors is the observation that B19V does not stably bind membrane-associated globoside in vitro (20) , indicating that B19V probably binds globoside jointly with other molecular structures present on cell membranes.
In the present studies, the interaction of B19V with cell surface receptors and the implication of this interaction in the capsid structure were studied. The cells chosen for this study were the erythropoietin (Epo)-dependent bone marrow megakaryoblastic leukemia cell line UT7/Epo, which are commonly used to study B19V infection. UT7/Epo cells support viral DNA replication and protein expression, however intracellular factors limit the production of infectious progeny virus. The results indicate that B19V interacts dynamically with cell surface receptors and that internalization is a complex process involving sequential steps. B19V binds initially to Gb4Cer, which triggers the externalization of VP1u. The modified capsid is then ready for a subsequent interaction. Whenever the second interaction is not possible, 
Materials and Methods
Cells and viruses. UT7/Epo cells were cultured in RPMI, 10% FCS and 2 U/ml of recombinant human erythropoietin (Epo; Janssen-Cilag, Midrand, South Africa) at 37°C and 7.5% CO 2 . A B19V-infected plasma sample was obtained from our donation center (Genotype 1; CSL Behring AG, Charlotte, NC). The viremic serum sample did not contain B19V-specific IgM or IgG antibodies. B19V was concentrated from the infected plasma sample by ultracentrifugation through 20% sucrose. The viral pellets were washed and resuspended in PBS. B19V titres were determined by quantitative PCR as DNA-containing particles per microliter. To obtain receptor-detached virus, UT7/Epo cells were infected with B19V at 4°C for 1h. The cells were repeatedly washed with PBS to remove unbound virus and further incubated in RPMI at 37°C for 1h. The cells were pelleted and the supernatant containing the detached virus was recovered and titres were determined as specified above. Baculovirus-expressed B19V-like empty particles (VLPs) containing VP1 and VP2 were kindly provided by R. Franssila (Helsinki, Finland) and were produced in High-5 cells as described elsewhere (15) . VP2-only empty particles, lacking VP1 were kindly provided by G. Elliott (Biotrin Technologies Ltd, Dublin, Ireland).
Antibodies.
A rabbit polyclonal antibody against VP1u (aa 142-163; referred as α-VP1u) was obtained as previously described (3) . Two monoclonal antibodies (mAbs), one specific for the most N-terminal region of VP1u (mAb 1418-1; aa 30-42; referred as α-N-VP1u) and the other recognizing only intact capsids (mAb 860-55D; referred as α-Caps), were kindly provided by S. Modrow (Regensburg, Germany).
The two mAbs were produced from peripheral blood mononuclear cells from normal, and were shown to be highly neutralizing (12, 16, 30) . For detection of B19V proteins by immunoblot, a mouse anti-B19V VPs antibody was used (US biologicals, Swampscott, MA). A globoside-specific mouse IgM mAb (AME-2, referred as α- Co-localization of cell surface receptors with B19V capsids. UT7/Epo cells were infected for 1h at 4°C (2x10 4 virions per cell) and intensively washed to remove unbound viruses. Detection of CD49e and Gb4Cer was performed as described above, but the human mAb against intact capsids (mAb 860-55D) was also applied (dilution 1:400 in PBSA). Before mounting with mowiol, nuclei were stained with DAPI (Invitrogen, Eugen, OR). As controls, uninfected cells and non-specific IgM/IgG isotype control antibodies were used. Cells were examined by confocal laser scanning microscopy.
Quantitative PCR. Amplification of B19V DNA and real-time detection of PCR products were performed by using the LightCycler system (Roche Diagnostics, Rotkreuz, Switzerland) with SYBR Green (Roche). PCR was carried out using the FastStart DNA SYBR Green kit (Roche) following the manufacturer's instructions.
Primers used for B19V-DNA amplification were; B19V-forward (5'-GGGCAGCCATTTTAAGTGTTT-3') and B19V-reverse (5'-GCACCACCAGTTATCGT TAGC-3'). As external standards, plasmids containing the genome of B19V were used in ten-fold dilutions. PCR specificity was verified using melting curve analysis.
The number of cells used for each experiment was determined by the quantification of the cell β-actin gene, as previously described (27) . Following washings to remove unbound virus, the cells were lysed and total DNA was extracted by using the DNeasy tissue kit (Qiagen, Valencia, CA). Viral DNA was quantified from three independent experiments as specified above. 
Analysis of B19V dynamics

Results
Globoside is the primary attachment receptor of B19V in UT7/Epo cells.
The expression of B19V receptors in UT7/Epo cells was quantitatively analyzed by flow cytometry. Expression levels of CD49e (Integrin alpha-5 subunit, which for a heterodimer with the beta-1 subunit) were high; 66% (±0.6%). Expression of Gb4Cer was also abundant (29%) but varied considerably with the cell passage (data not shown). Expression of Ku80 in UT7/Epo cells was insignificant (0.25% ±0.07%) (Fig.   1A ), confirming the results obtained in previous studies (39) . Therefore, Ku80
autoantigen does not play a role in B19V binding to UT7/Epo cells.
Immunofluorescence staining of cells with antibodies against Gb4Cer confirmed that the Gb4Cer is abundantly expressed, although it is not homogeneously distributed among the cells (Fig. 1B) . Double staining with an antibody against the viral receptor and an antibody against intact capsids showed extensive co-localization of B19V
with Gb4Cer and to a lesser extent with CD49e ( Fig. 2A) . Virus attachment was disturbed in cells pre-incubated with anti-Gb4Cer, in contrast no effect was observed in cells pre-incubated with anti-Ku80 or anti-CD49e (Fig. 2B ), indicating that preliminary attachment of B19V to UT7/Epo cells is achieved through Gb4Cer.
A large proportion of cell-bound capsids does not internalize and instead dissociate from the receptor. Binding of native capsids to Gb4Cer is not stable for a large proportion of capsids, which were rapidly detached when the temperature was changed from 4°C to 37°C. The capsids that remained stably bound became progressively internalized (Fig. 3A) . Virus detachment was also receptor dissociation kinetics were slower at 4°C than at 37°C, however and independently of the temperature, the total amount of viruses that became finally detached was approximately two thirds of the total initially bound (Fig. 3B ).
Tendencies diverged with prolonged incubation times. At 4°C, where internalization and receptor recycling is impaired, a progressive and slow detachment of all viruses was observed. However, prolonged incubation at 37°C resulted in a slow and progressive re-attachment of the receptor-dissociated capsids, probably to newly expressed and/or recycled receptors (Fig. 3B ). This data suggests that rebinding of viruses to the same receptors from which they have dissociated does not occur.
The receptor-detached virus shows superior cell binding capacity and infectivity. Cell binding and infectivity were compared between receptor-detached and native virus. When added in equal numbers to uninfected cells, the receptordetached virus showed a superior cell binding capacity as well as a superior infectivity than the native virus (Fig. 4) . This result suggests the existence of beneficial structural differences in the detached particles improving the infection. (Fig. 5B) . When the receptor-bound capsids were further incubated for 1 h at 4°C, to avoid virus internalization and initiate virus detachment (as shown in Fig.   3B ), all capsids remaining stably bound to the cells had VP1u accessible (Fig. 5C ),
Binding of B19V to UT7/Epo cells triggers conformational changes in
suggesting that the external position of VP1u assists to stabilize the receptor-capsid complex.
Studies of capsid disassembly in vitro suggest that the conformational transitions that lead to the exposure of VP1u also lead to the externalization of the viral genome (10, 11, 29) . It was therefore of interest to examine whether the receptor-induced externalization of VP1u would also result in the accessibility of the viral DNA. Cell-bound viruses were immunoprecipitated as described above. The immunoprecipitated capsids were treated with DNase I prior to DNA extraction and quantification. The results showed that the viral DNA remained encapsidated (Fig.   5D ). Additionally, receptor-detached capsids, which also have VP1u accessible, were directly incubated with DNase I or AccI, which cleaves a sequence within the 3' palindromic sequence. These treatments had no effect on the viral infectivity, indicating that despite the structural changes leading to VP1u exposure, the viral genome remained fully encapsidated and infectious (Fig. 5E ).
Purified globoside can trigger the externalization of VP1u. In addition to
Gb4Cer, Ku80 and integrin α5β1 have been recognized as coreceptors of B19V (25, 36) . However, expression analysis of these receptors in UT7/Epo cells by flow cytometry indicated that only a negligible subset of UT7/Epo cells expressed Ku80 (Fig. 1A) . Additionally, blocking CD49e with an antibody disturbing ligand binding had no effect in B19V attachment (Fig. 2B) (5, 35) . However, the observed conformational changes might also result from an interaction of B19V with Gb4Cer jointly with other structures on the cell membrane. In order to examine whether Gb4Cer alone is able to trigger the exposure of VP1u, B19V capsids were incubated with purified Gb4Cer receptor. As shown in Fig. 6 , an increasing amount of B19V capsids externalized
VP1u following incubation with increasing concentrations of purified Gb4Cer.
Receptor-bound capsids acquire superior stability compared to receptor-detached and native particles. We have previously shown that heatinduced DNA accessibility was remarkably more pronounced in B19V than in any other parvovirus, explaining the lower resistance of B19V to inactivation treatments (24) . This difference was also evident under conditions mimicking endosomal acidification (pH 6.5 to 5), which triggered the externalization of B19V DNA but not of minute virus of mice (MVM) DNA (29) . Accordingly, trafficking of incoming B19V through the acidic endosomal compartment would presumably cause the degradation of the exposed viral DNA by lysosomal enzymes. We therefore analyzed whether the receptor-induced structural changes in the B19V capsid would also modify the overall stability of the virion. Cell-bound, receptor-detached and native capsids (alone or in the presence of cells) were exposed to increasing temperatures for 3 min. Subsequently, the samples were cooled and incubated with DNase I at 4°C. Total DNA was extracted and the intact viral DNA was quantified. The results
showed that receptor-bound capsids were markedly more resistant to heat that the native and the detached particles (Fig. 7) . Interestingly, although VP1u externalization is also detected in the detached capsids, the stability of the capsid The receptor-induced externalization of VP1u facilitates virus internalization. Apart from Gb4Cer, B19V might interact with additional structures at the cell surface, notably integrins and such interactions are thought to play a role in virus internalization (36, 37, 38) . It is tempting to speculate that the newly exposed VP1u domains interact with integrin subunits and virus internalization ensues as a consequence. In order to examine the role of the exposed VP1u in virus internalization, the binding and internalization of native virions and VLPs (empty capsids composed of VP1 and VP2) were compared to VP2-only particles (empty capsids devoid of VP1) by immunofluorescence microscopy. Western blot analysis of the different capsid preparations confirmed that VP2-only particles did not contain VP1 (Fig. 8A) . All particles were able to bind UT7/Epo cells at 4°C with apparently similar efficiency. However, following incubation at 37°C to allow virus internalization, VP2-only particles were unable to internalize and were instead progressively detached from the cells being hardly detectable after 90 min. In contrast, native virus and VLPs rapidly internalized and accumulated in a region of the cytoplasm with no detectable differences (Fig. 8B) . To further confirm this observation, following virus internalization for 30 min at 37°C, the cells were shortly trypsinized to remove uninternalized capsids. While in cells infected with native virus and VLPs, the capsids appear with the typical intracellular accumulation, no significant signal was detected in the cells incubated with VP2-only particles (Fig. 8B) . Both antibodies have been previously found to be highly neutralizing (12, 16, 30) . In our assay, the antibodies were highly neutralizing when added during virus binding.
However, in contrast to α-Caps, α-N-VP1u was not neutralizing when added after virus binding (Fig. 9A ). This result suggests that the epitope recognized by α-N-VP1u
is involved in binding events that hinder its accessibility to the antibody. In our previous studies we have shown that α-N-VP1u does not influence the PLA 2 activity detected following binding of AAV-2 to heparin (22) . The expansion of the fivefold axis pore is believed to facilitate the externalization of VP1u, which in all parvoviruses studied so far, occurs during the intracellular trafficking of the capsid mediated by the acidified endosomal environment (18, 23, 28, 32, 33) . Therefore, B19V would be unique among parvoviruses in that the conformational changes leading to the accessibility of VP1u sequences do not occur inside the cell, but prematurely at the cell membrane. The question remains whether VP1u is not accessible because it is buried within the capsid, similar to other parvoviruses, or it is already external but not accessible to antibodies due to a particular "unattainable"
conformation. An argument to the latter hypothesis is that the fivefold channel, which is suggested to be used during VP1u externalization, is closed in the B19V particle (1, 8) . However, it cannot be excluded that structural rearrangements during the infection, similar to those observed in AAV-2 capsids bound to heparin (22) eventually open or expand a flexible pore. It is also not known whether the observed rearrangements concern the complete VP1u or some domains. In our previous studies, the accessibility of two distant regions of VP1u was examined. One region at the N-terminal part, which clusters numerous neutralizing epitopes and a second (Fig. 7) .
On the contrary, receptor-bound capsids were remarkably more resistant than native or detached capsids. The increased capsid rigidity might assist the incoming viruses during entry. In our previous studies, we showed that B19V genome, in contrast to other parvoviruses, can be easily externalized upon mild acidification similar to that found in endosomes/lysosomes (29) . Therefore, the natural resistance of B19V B19V acquired a remarkable superior stability. The increase resistance was, in contrast to VP1u exposure, reversible upon receptor-detachment (Fig. 7) . In this way, B19V capsids would become more resistant when needed, but become again flexible upon receptor dissociation and endosomal escape to facilitate uncoating.
It is reasonable to expect that the receptor-induce conformational changes are necessary for subsequent interactions events leading to virus internalization. In line with this assumption is the fact that VP2-only capsids, lacking VP1 (Fig. 8A) , were unable to internalize (Fig. 8B) . Moreover, an antibody (mAb 1418-1; referred as α-N- Previous studies demonstrated that B19V does not bind to isolated Gb4Cer (20) , suggesting that B19V binds Gb4Cer at the cell surface as part of a complex involving other structures. However, incubation of B19V particles with increasing concentrations of purified Gb4Cer triggered changes in the original inaccessible configuration of VP1u becoming increasingly accessible on the capsid surface ( Fig.   6 ). A possible explanation of our results is that binding of B19V to isolated Gb4Cer is highly unstable due to the lack of required stabilizing coreceptors. This might also explain the detachment of a large proportion of cell-bound particles observed in this studies (Fig. 3) . Interestingly, reattachment of receptor-dissociated B19V to the receptors from where they detached is not detectable at 4°C and occurs only after several hours at 37°C, probably to newly expressed and/or recycled receptors (Fig.   3B ). In contrast, when the detached virus is added to uninfected cells, these particles bind with a higher efficiency and are more infectious than the native virus (Fig. 4) .
This observation might represent a strategy to avoid repetitive "abortive" attachments to the same receptor and in this way increase the probability of productive bindings leading to virus internalization. on June 30, 2017 by guest
